Necessity of a Standardized Reporting System of Antiphospholipid Antibody Tests: Relevance for COVID-19

참고문헌 (10)

1. Jearn LH, "Is rheumatoid factor really associated with deep venous thrombosis?", Clin Chem, 61, pp.1546~1547 (2015)
2. Zhang Y, "Coagulopathy and antiphospholipid antibodies in patients with Covid-19", N Engl J Med, 382, pp.e38~ (2020)
3. Harzallah I, "Lupus anticoagulant is frequent in patients with Covid-19", J Thromb Haemost, 18, pp.2064~2065 (2020)
4. Beyrouti R, "Characteristics of ischaemic stroke associated with COVID-19", J Neurol Neurosurg Psychiatry, 91, pp.889~891 (2020)
5. Sung J, "Coronavirus disease 2019 (COVID-19) infection associated with antiphospholipid antibodies and four-extremity deep vein thrombosis in a previously healthy female", Cureus, 12, pp.e8408~ (2020)
6. Hossri S, "Clinically significant anticardiolipin antibodies associated with COVID-19", J Crit Care, 59, pp.32~34 (2020)
7. Devreese KMJ, "Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH", J Thromb Haemost, 16, pp.809~813 (2018)
8. Gardiner C, "Diagnosis of antiphospholipid syndrome in routine clinical practice", Lupus, 22, pp.18~25 (2013)
9. Schouwers SM, "Lupus anticoagulant (LAC) testing in patients with inflammatory status: does C-reactive protein interfere with LAC test results?", Thromb Res, 125, pp.102~104 (2010)
10. Pengo V, "Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant", Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis, 2009, pp.7, 1737~1740

관련 논문AI추천